CYTK vs MAS · rev $28.6M vs P/E 18, rev $7.56B
Cytokinetics Inc (CYTK) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
CYTK currently screens at market cap $4.05B. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the CYTK and MAS stock pages for the full models.
Not investment advice.